Deferred Systemic Therapy in Patients With Metastatic Renal Cell Carcinoma-Reference-Cited by-同舟云学术

Deferred Systemic Therapy in Patients With Metastatic Renal Cell Carcinoma

Published:2015-06 Issue:3 Volume:13 Page:e159-e166
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Mitchell Aaron P.,Hirsch Bradford R.,Harrison Michael R.,Abernethy Amy P.,George Daniel J.

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference28 articles.

1. The role of metastasectomy in renal cell carcinoma in the era of targeted therapy;Ljungberg;Curr Urol Rep,2013

2. Role of metastasectomy for metastatic renal cell carcinoma in the era of targeted therapy;Kim;World J Urol,2014

3. SEER Cancer Statistics Review 1975-2010. Available at: http://seer.cancer.gov/csr/1975_2010/browse_csr.php?sectionSEL=11&pageSEL=sect_11_zfig.05.html. Accessed December 8, 2013.

4. Metastatic renal cell carcinoma;Flanigan;Curr Treat Options Oncol,2003

5. Diagnosis and management of renal cell carcinoma. A clinical and pathologic study of 309 cases;Skinner;Cancer,1971

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. STX4 as a potential biomarker for predicting prognosis and guiding clinical treatment decisions in clear cell renal cell carcinoma;Heliyon;2024-01

2. Comprehensive analysis to identify the RP11–478C19.2/ E2F7 axis as a novel biomarker for treatment decisions in clear cell renal cell carcinoma;Translational Oncology;2022-11

3. A predictive signature based on enhancer RNA associates with immune infiltration and aids treatment decision in clear cell renal cell carcinoma;Frontiers in Oncology;2022-10-12

4. Initial active surveillance for patients with metastatic renal cell carcinoma: 10 years' experience at a regional cancer Centre;Cancer Medicine;2022-10-07

5. Outcomes following cytoreductive nephrectomy without immediate postoperative systemic therapy for patients with synchronous metastatic renal cell carcinoma;Urologic Oncology: Seminars and Original Investigations;2022-04